Site US10022 — Springfield, Oregon

Site US10022 is a clinical research site located in Springfield, Oregon, United States 97477.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US10022 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springfield

Browse all research sites in Oregon · View every site in Springfield

• Oregon Cardiology Sacred Heart at Riverbend Hospital
• Oregon Health and Science University
• Oregon Urology Institute
• Cascade Medical Research Institute
• Oregon Research Behavioral Intervention Strategies, Inc.
• Willamette Valley Cancer Institute and Research Center
• Oregon Research Institute
• Research Site
• Willamette Valley Cancer Center
• Oregon Neurology Associates
• Willamette Valley Cancer Insitute and Research Center
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10022?

Site US10022 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10022 conducted?

Site US10022 has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer.

Is Site US10022 accredited by Crixeo Clinical Trials?

Site US10022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.